Developed in collaboration with Yuwell Medical, Voxi 5 presents a viable option for patients seeking reliable stationary oxygen therapy, delivering 1-5 L/min of quiet 1, pure 2, continuous flow oxygen ...

Inogen has continued to struggle, with growth in the rental business overshadowed by declines in direct-to-consumer sales, volatility in business-to-business sales, and pricing pressures. Inogen has ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (“POC”) space. The optimism, led by solid first-quarter 2025 ...

Inogen stock got crushed in the tech rout, giving investors a second bite at the apple. Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more.

Inogen's price performance has been poor this year, but a closer look at the numbers suggests that the market's negativity may be unwarranted. Management is actively taking steps to address the ...

A month has gone by since the last earnings report for Inogen (INGN). Shares have added about 6.8% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent ...